UBS initiates coverage on Globus Medical (NYSE: GMED) with a Neutral rating.The analyst is coming out bullish on the US ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE